ALK(SZ:002940) Xin Lang Cai Jing·2025-11-19 06:15Core Points - On November 19, Angli康's stock dropped by 5.16%, trading at 40.47 CNY per share, with a transaction volume of 484 million CNY and a turnover rate of 6.31%, resulting in a total market capitalization of 8.164 billion CNY [1] - Angli康, established on December 30, 2001, and listed on October 23, 2018, is primarily engaged in the research, production, and sales of chemical raw materials and formulations, with its main revenue sources being formulations (43.46%), raw materials (39.82%), specialty intermediates (12.44%), others (3.72%), and pharmaceutical excipients (0.56%) [1] Shareholder Analysis - Among Angli康's top ten circulating shareholders, a fund under China Europe Fund holds a significant position. The China Europe Medical Health Mixed A Fund (003095) reduced its holdings by 3.351 million shares in the third quarter, now holding 3.0863 million shares, which accounts for 1.67% of the circulating shares. The estimated floating loss today is approximately 6.7899 million CNY [2] - The China Europe Medical Health Mixed A Fund (003095) was established on September 29, 2016, with a current scale of 16.977 billion CNY. Year-to-date returns are 20.05%, ranking 4065 out of 8138 in its category; the one-year return is 16.2%, ranking 4684 out of 8055; and since inception, the return is 107.2% [2] Fund Manager Information - The fund managers of the China Europe Medical Health Mixed A Fund (003095) are Ge Lan and Zhao Lei. As of the report, Ge Lan has a cumulative tenure of 10 years and 298 days, with the fund's total asset scale at 43.544 billion CNY, achieving the best return of 107.89% and the worst return of -35.13% during her tenure [3] - Zhao Lei has a cumulative tenure of 139 days, with the fund's total asset scale at 32.954 billion CNY, achieving the best return of 8.11% and the worst return of 7.8% during his tenure [3]